Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Revenue | ||||
| Total | $ 4,255,906 | $ 1,402,511 | $ 8,214,030 | $ 1,420,681 |
| Cost of Revenue | ||||
| Costs of revenue | 2,898,411 | 857,556 | 5,524,079 | 869,356 |
| Gross Profit | 1,357,495 | 544,955 | 2,689,951 | 551,325 |
| Operating expenses | ||||
| Payroll and related expenses | 1,011,733 | 685,974 | 2,065,693 | 1,137,426 |
| General and administrative expenses | 1,916,390 | 1,429,935 | 3,337,811 | 1,879,489 |
| Professional and consulting fees | 667,206 | 181,614 | 1,753,481 | 467,180 |
| Marketing and business development expense | 758,143 | 156,778 | 1,297,870 | 240,439 |
| Bad debt expense | 3,025,000 | 3,025,000 | ||
| Total | 4,353,472 | 5,479,301 | 8,454,855 | 6,749,534 |
| Operating loss | (2,995,977) | (4,934,346) | (5,764,904) | (6,198,209) |
| Other income (expense) | ||||
| Interest expense | (2,809,439) | (830,196) | (4,141,183) | (1,784,845) |
| Change in fair value of derivative liability | (1,268,162) | |||
| Loss on settlement of derivative liability | (3,881,922) | |||
| Loss on exchange transaction | (2,215,127) | (2,215,127) | ||
| Loss on sale of equipment | (80,289) | |||
| Interest income | 23,984 | 47,672 | ||
| Other income | 1,327 | 16,603 | 3,370 | 31,432 |
| Total | (5,023,239) | (789,609) | (11,583,313) | (1,705,741) |
| Net loss | $ (8,019,216) | $ (5,723,955) | $ (17,348,217) | $ (7,903,950) |
| Net loss per share | ||||
| Basic (in Dollars per share) | $ (3.08) | $ (45.9) | $ (7.66) | $ (69.48) |
| Diluted (in Dollars per share) | $ (3.08) | $ (45.9) | $ (7.66) | $ (69.48) |
| Weighted average shares outstanding: | ||||
| Basic (in Shares) | 2,600,982 | 124,718 | 2,266,132 | 113,765 |
| Diluted (in Shares) | 2,600,982 | 124,718 | 2,266,132 | 113,765 |
| Sales | ||||
| Revenue | ||||
| Total | $ 4,255,906 | $ 1,402,511 | $ 8,214,030 | $ 1,420,681 |
| Cost of revenue | ||||
| Cost of Revenue | ||||
| Costs of revenue | $ 2,898,411 | $ 857,556 | $ 5,524,079 | $ 869,356 |
| X | ||||||||||
- Definition Loss on exchange transaction. No definition available.
|
| X | ||||||||||
- Definition Amount of loss on settlement of derivative liability. No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The total expense recognized in the period for promotion, public relations, and brand or product advertising. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense (reversal of expense) for expected credit loss on accounts receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|